ERBB2 and breast cancer: mimic of endogenous hormones, interact with signaling transduction pathways, such as HER2 signaling, modulate of key enzymes involved in estrogen metabolism, increase pro-oncogenic c-Myc expression in ER+/HER2+ BC cells, promote EMT [135]